[go: up one dir, main page]

NO20050658L - Methods for the Treatment of Erectile Dysfunction in Men - Google Patents

Methods for the Treatment of Erectile Dysfunction in Men

Info

Publication number
NO20050658L
NO20050658L NO20050658A NO20050658A NO20050658L NO 20050658 L NO20050658 L NO 20050658L NO 20050658 A NO20050658 A NO 20050658A NO 20050658 A NO20050658 A NO 20050658A NO 20050658 L NO20050658 L NO 20050658L
Authority
NO
Norway
Prior art keywords
methods
erectile dysfunction
men
treatment
patient
Prior art date
Application number
NO20050658A
Other languages
Norwegian (no)
Inventor
James L Yeager
Nadir Bueyuektimkin
Servet Bueyuektimkin
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/236,485 external-priority patent/US7105571B2/en
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of NO20050658L publication Critical patent/NO20050658L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives fremgangsmåter for behandling av erektil dysfunksjon hos en pasient som lider av en samtidig, sykelig tilstand, som omfatter å plassere i fossa navicularis hos pasienten en ereksjons-bevirkende mengde av et halvfast, vasoaktivt prostaglandinpreparat.Methods for treating erectile dysfunction are described in a patient suffering from a concomitant, morbid condition, which includes placing in the fossa navicularis of the patient an erectile dysfunctional amount of a semi-solid, vasoactive prostaglandin preparation.

NO20050658A 2002-09-06 2005-02-08 Methods for the Treatment of Erectile Dysfunction in Men NO20050658L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/236,485 US7105571B2 (en) 2000-01-10 2002-09-06 Prostaglandin compositions and methods of treatment for male erectile dysfunction
US48327803P 2003-06-27 2003-06-27
PCT/US2003/027885 WO2004022064A1 (en) 2002-09-06 2003-09-05 Methods of treatment of male erectile dysfunction

Publications (1)

Publication Number Publication Date
NO20050658L true NO20050658L (en) 2005-04-01

Family

ID=31980977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050658A NO20050658L (en) 2002-09-06 2005-02-08 Methods for the Treatment of Erectile Dysfunction in Men

Country Status (10)

Country Link
EP (1) EP1534297A1 (en)
JP (1) JP2006512291A (en)
KR (1) KR20050057245A (en)
CN (1) CN1674912A (en)
AU (1) AU2003273291A1 (en)
CA (1) CA2493723A1 (en)
EA (1) EA200500452A1 (en)
IL (1) IL166273A0 (en)
NO (1) NO20050658L (en)
WO (1) WO2004022064A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
KR20050119136A (en) * 2003-03-21 2005-12-20 넥스메드 홀딩스 인코포레이티드 Angiogenesis promotion by prostaglandin compositions and methods
AU2004224413A1 (en) * 2003-03-21 2004-10-07 Nexmed (Holdings), Inc. Prostaglandin compositions for the treatment of erectile dysfunction
EP3266458A1 (en) 2016-07-05 2018-01-10 Fagron B.V. Method and composition and kit for treating erectile dysfunction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
CA2468631A1 (en) * 2002-02-15 2003-08-28 Nexmed (Holdings), Inc. Prostaglandin composition for the treatment of erectile dysfunction

Also Published As

Publication number Publication date
EP1534297A1 (en) 2005-06-01
AU2003273291A1 (en) 2004-03-29
KR20050057245A (en) 2005-06-16
CN1674912A (en) 2005-09-28
EA200500452A1 (en) 2005-10-27
WO2004022064A1 (en) 2004-03-18
IL166273A0 (en) 2006-01-15
JP2006512291A (en) 2006-04-13
CA2493723A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
MY169308A (en) Treatment of tnf? related disorders
GB2432939A (en) A frequency and voltage scaling architecture
NO20055415L (en) Humanized antibodies that recognize beta-amyloid peptide
NO20061080L (en) Condensed pyramidine compounds as inhibitors of voltage controlled ion channels
WO2007087468A3 (en) Adiponectin for treatment of various disorders
TW200505829A (en) Protease inhibitors for coronaviruses and sars-cov and the use thereof
NO20061092L (en) Heteroarvlaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
AU2001231763A1 (en) Dosing regimen
WO2004014352A3 (en) Methods for treating carbonic anhydrase mediated disorders
NO20091296L (en) Procedure for the treatment of thrombolytic agents
WO2006131737A3 (en) Method and composition for treating inflammatory disorders
WO2002036123A3 (en) New treatments for restless legs syndrome
WO2005044199A3 (en) Combination of proton pump inhibitor and sleep aid
NO20053042L (en) Use of spongosine (2-methoxyadenosine) for the treatment of pain, especially hyperalgesia.
DK1228708T4 (en) Milk-derived basic protein fraction as a means of reducing high blood pressure
NO20054371L (en) Somatostatin-dopamine chimeric analogs
BRPI0506970A (en) alpha-aminoamide derivatives useful in treating lower urinary tract disorders
NO20063300L (en) Methods for treating acute inflammation in animals with p38 MAP kinase inhibitors
NO20062256L (en) Hydroxyalkyl-substituted pyrido-7-pyrimidin-7-ones
NO20050658L (en) Methods for the Treatment of Erectile Dysfunction in Men
WO2007038506A3 (en) Method for the treatment of cachexia
WO2002056876A3 (en) Treatment for snoring
WO2003080665A3 (en) Antibody that binds to a dimer of a prion protein for the treatment of tse infection
MXPA05008347A (en) Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis.
UA103594C2 (en) Method for treating uveitis